Ginkgo Bioworks Holdings (DNA) Cash from Investing Activities (2020 - 2026)

Ginkgo Bioworks Holdings (DNA) has 7 years of Cash from Investing Activities data on file, last reported at $23.1 million in Q1 2026.

• For the quarter ending Q1 2026, Cash from Investing Activities rose 111.64% year-over-year to $23.1 million; the trailing twelve-month figure through Mar 2026 stood at -$18.5 million (up 92.58% YoY), and the FY2025 full-year result was -$240.3 million, down 286.09% from the prior year.
• Cash from Investing Activities for Q1 2026 stood at $23.1 million, down from $95.1 million in the prior quarter.
• Across five years, Cash from Investing Activities topped out at $95.1 million in Q4 2025 and bottomed at -$198.7 million in Q1 2025.
• The 5-year median for Cash from Investing Activities is -$14.7 million (2022), against an average of -$25.1 million.
• Peak annual rise in Cash from Investing Activities reached 826.78% in 2025, while the deepest fall reached 1540.66% in 2025.
• A 5-year view of Cash from Investing Activities shows it stood at $29.7 million in 2022, then slumped by 256.94% to -$46.7 million in 2023, then soared by 71.97% to -$13.1 million in 2024, then soared by 826.78% to $95.1 million in 2025, then slumped by 75.68% to $23.1 million in 2026.
• The last three Cash from Investing Activities figures came in at $23.1 million (Q1 2026), $95.1 million (Q4 2025), and -$72.8 million (Q3 2025), per Business Quant data.

Peer Comparison